To discover what was a US citizen, Dr Randall which has obtained by law to be able to cure with cannabis derivatives, opening the way to this therapy for this specific disorder of the view. His choice, in fact, has also confirmed in subsequent clinical studies. Already since 1985 the FDA (Food and Drug Administration), i.e. the American organization that controls the medicinal products in the USA has permitted the sale of a synthetic cannabinoid, i.e. produced in the laboratory, the dronabinol, able to counteract the nausea in who is subjected to chemotherapy. Recent studies have shown that a synthetic cannabinoid, dronabinol, even manages to whet the appetite, producing a significant weight gain in people with AIDS and affected by the so-called syndrome of decay. It was also presented a study that has clarified that the cannabis derivatives do not interfere with the antiviral drugs, i.e. those medicinal products used for fighting viruses such as HIV, which causes AIDS. The cannabidiol, i.e. a nonpsychoactive cannabinoid, also seems to have anticonvulsionanti properties, i.e. that help to combat the convulsions, one of the most common symptoms of epilepsy. Studies carried out on this disease, however, are still at the experimental stage, even if many patients who have voluntarily subjected to experiments, argue that the cannabidiol has helped them to overcome more easily the convulsions. This is also why the British medical association, one of the British authorities more authoritative in the health field, has recently recommended to further research on the action of this substance. The morbus Alzehimer, that of Parkinson, Huntington's Chorea, are all diseases as defined neurodegenerative diseases because they are caused by a degeneration of nerve cells. Recent studies conducted by international researchers have discovered that the cannabidiol, a component not psicoattivo of cannabis, helps protect the brain cells. The research, published in the scientific journal "Proceedings of National Academy", has demonstrated that the cannabidiol acts as an antioxidant, i.e. combats aging and death of neurons. Even if the studies are always at the experimental stage this discovery opens up new possibilities in the treatment of stroke and neurodegenerative disorders. The legislation in Italy and in the world adjusts the cannabis Italy - the legislation to consult is the Dpr number 309 of 9 October 1990: in our country are not for sale allopathic treatments which use cannabis indica, which instead is present in some homeopathic medicines, even if in small doses (are measured in nanograms, i.e. in billionths of a gram). Abroad, and exactly in the USA, Israel, Germany, Great Britain and the Netherlands there are two synthetic cannabinoids already in trade: dronabinol and nabilone. These drugs are sold on prescription to cure the side effects of chemotherapy and to stimulate the appetite in Aids patients, although by 2002 it will become possible to use them to combat the spasms of multiple sclerosis and other disorders. The Institute of Medicine of the National Academy of Sciences of the United States, last year has officially recognized the benefits derived from cannabis in the treatment of certain diseases. In the same document, however, the American organization has brought to the attention of the scientific world the problem of finding an administration of cannabis is different from tobacco smoke. In fact, the inhalation of cannabinoids through the smoke causes damage similar to those of the cigarettes that range from a simple irritation of the respiratory tract to problems much more serious, as the lung cancer. For this reason the international scientific community is trying administration methods alternative to smoke that, in sick people, has effects even more harmful. For now it is arrived to produce as an alternative to smoking pills, but their cost is very high, also the absorption through the gastrointestinal tract is very slow and a large part of the active principle is inactivated by the passage in the liver. Another way of administration that you are experiencing is that inhalant, i.e. the active principles of cannabis are inhaled as occurs during an aerosol and plasters that release through the skin these active substances. To discover what was a US citizen, Dr Randall which has obtained by law to be able to cure with cannabis derivatives, opening the way to this therapy for this specific disorder of the view. His choice, in fact, has also confirmed in subsequent clinical studies. Already since 1985 the FDA (Food and Drug Administration), i.e. the American organization that controls the medicinal products in the USA has permitted the sale of a synthetic cannabinoid, i.e. produced in the laboratory, the dronabinol, able to counteract the nausea in who is subjected to chemotherapy. Recent studies have shown that a synthetic cannabinoid, dronabinol, even manages to whet the appetite, producing a significant weight gain in people with AIDS and affected by the so-called syndrome of decay. It was also presented a study that has clarified that the cannabis derivatives do not interfere with the antiviral drugs, i.e. those medicinal products used for fighting viruses such as HIV, which causes AIDS. The cannabidiol, i.e. a nonpsychoactive cannabinoid, also seems to have anticonvulsionanti properties, i.e. that help to combat the convulsions, one of the most common symptoms of epilepsy. Studies carried out on this disease, however, are still at the experimental stage, even if many patients who have voluntarily subjected to experiments, argue that the cannabidiol has helped them to overcome more easily the convulsions. This is also why the British medical association, one of the British authorities more authoritative in the health field, has recently recommended to further research on the action of this substance. The morbus Alzehimer, that of Parkinson, Huntington's Chorea, are all diseases as defined neurodegenerative diseases because they are caused by a degeneration of nerve cells. Recent studies conducted by international researchers have discovered that the cannabidiol, a component not psicoattivo of cannabis, helps protect the brain cells. The research, published in the scientific journal "Proceedings of National Academy", has demonstrated that the cannabidiol acts as an antioxidant, i.e. combats aging and death of neurons. Even if the studies are always at the experimental stage this discovery opens up new possibilities in the treatment of stroke and neurodegenerative disorders. The legislation in Italy and in the world adjusts the cannabis Italy - the legislation to consult is the Dpr number 309 of 9 October 1990: in our country are not for sale allopathic treatments which use cannabis indica, which instead is present in some homeopathic medicines, even if in small doses (are measured in nanograms, i.e. in billionths of a gram). Abroad, and exactly in the USA, Israel, Germany, Great Britain and the Netherlands there are two synthetic cannabinoids already in trade: dronabinol and nabilone. These drugs are sold on prescription to cure the side effects of chemotherapy and to stimulate the appetite in Aids patients, although by 2002 it will become possible to use them to combat the spasms of multiple sclerosis and other disorders. The Institute of Medicine of the National Academy of Sciences of the United States, last year has officially recognized the benefits derived from cannabis in the treatment of certain diseases. In the same document, however, the American organization has brought to the attention of the scientific world the problem of finding an administration of cannabis is different from tobacco smoke. In fact, the inhalation of cannabinoids through the smoke causes damage similar to those of the cigarettes that range from a simple irritation of the respiratory tract to problems much more serious, as the lung cancer. For this reason the international scientific community is trying administration methods alternative to smoke that, in sick people, has effects even more harmful. For now it is arrived to produce as an alternative to smoking pills, but their cost is very high, also the absorption through the gastrointestinal tract is very slow and a large part of the active principle is inactivated by the passage in the liver. Another way of administration that you are experiencing is that inhalant, i.e. the active principles of cannabis are inhaled as occurs during an aerosol and plasters that release through the skin these active substances. To discover what was a US citizen, Dr Randall which has obtained by law to be able to cure with cannabis derivatives, opening the way to this therapy for this specific disorder of the view. His choice, in fact, has also confirmed in subsequent clinical studies. Already since 1985 the FDA (Food and Drug Administration), i.e. the American organization that controls the medicinal products in the USA has permitted the sale of a synthetic cannabinoid, i.e. produced in the laboratory, the dronabinol, able to counteract the nausea in who is subjected to chemotherapy. Recent studies have shown that a synthetic cannabinoid, dronabinol, even manages to whet the appetite, producing a significant weight gain in people with AIDS and affected by the so-called syndrome of decay. It was also presented a study that has clarified that the cannabis derivatives do not interfere with the antiviral drugs, i.e. those medicinal products used for fighting viruses such as HIV, which causes AIDS. The cannabidiol, i.e. a nonpsychoactive cannabinoid, also seems to have anticonvulsionanti properties, i.e. that help to combat the convulsions, one of the most common symptoms of epilepsy. Studies carried out on this disease, however, are still at the experimental stage, even if many patients who have voluntarily subjected to experiments, argue that the cannabidiol has helped them to overcome more easily the convulsions. This is also why the British medical association, one of the British authorities more authoritative in the health field, has recently recommended to further research on the action of this substance. The morbus Alzehimer, that of Parkinson, Huntington's Chorea, are all diseases as defined neurodegenerative diseases because they are caused by a degeneration of nerve cells. Recent studies conducted by international researchers have discovered that the cannabidiol, a component not psicoattivo of cannabis, helps protect the brain cells. The research, published in the scientific journal "Proceedings of National Academy", has demonstrated that the cannabidiol acts as an antioxidant, i.e. combats aging and death of neurons. Even if the studies are always at the experimental stage this discovery opens up new possibilities in the treatment of stroke and neurodegenerative disorders. The legislation in Italy and in the world adjusts the cannabis Italy - the legislation to consult is the Dpr number 309 of 9 October 1990: in our country are not for sale allopathic treatments which use cannabis indica, which instead is present in some homeopathic medicines, even if in small doses (are measured in nanograms, i.e. in billionths of a gram). Abroad, and exactly in the USA, Israel, Germany, Great Britain and the Netherlands there are two synthetic cannabinoids already in trade: dronabinol and nabilone. These drugs are sold on prescription to cure the side effects of chemotherapy and to stimulate the appetite in Aids patients, although by 2002 it will become possible to use them to combat the spasms of multiple sclerosis and other disorders. The Institute of Medicine of the National Academy of Sciences of the United States, last year has officially recognized the benefits derived from cannabis in the treatment of certain diseases. In the same document, however, the American organization has brought to the attention of the scientific world the problem of finding an administration of cannabis is different from tobacco smoke. In fact, the inhalation of cannabinoids through the smoke causes damage similar to those of the cigarettes that range from a simple irritation of the respiratory tract to problems much more serious, as the lung cancer. For this reason the international scientific community is trying administration methods alternative to smoke that, in sick people, has effects even more harmful. For now it is arrived to produce as an alternative to smoking pills, but their cost is very high, also the absorption through the gastrointestinal tract is very slow and a large part of the active principle is inactivated by the passage in the liver.  Another way of administration that you are experiencing is that inhalant, i.e. the active principles of cannabis are inhaled as occurs during an aerosol and plasters that release through the skin these active substances. To discover what was a US citizen, Dr Randall which has obtained by law to be able to cure with cannabis derivatives, opening the way to this therapy for this specific disorder of the view. His choice, in fact, has also confirmed in subsequent clinical studies. Already since 1985 the FDA (Food and Drug Administration), i.e. the American organization that controls the medicinal products in the USA has permitted the sale of a synthetic cannabinoid, i.e. produced in the laboratory, the dronabinol, able to counteract the nausea in who is subjected to chemotherapy. Recent studies have shown that a synthetic cannabinoid, dronabinol, even manages to whet the appetite, producing a significant weight gain in people with AIDS and affected by the so-called syndrome of decay. It was also presented a study that has clarified that the cannabis derivatives do not interfere with the antiviral drugs, i.e. those medicinal products used for fighting viruses such as HIV, which causes AIDS. The cannabidiol, i.e. a nonpsychoactive cannabinoid, also seems to have anticonvulsionanti properties, i.e. that help to combat the convulsions, one of the most common symptoms of epilepsy. Studies carried out on this disease, however, are still at the experimental stage, even if many patients who have voluntarily subjected to experiments, argue that the cannabidiol has helped them to overcome more easily the convulsions. This is also why the British medical association, one of the British authorities more authoritative in the health field, has recently recommended to further research on the action of this substance. The morbus Alzehimer, that of Parkinson, Huntington's Chorea, are all diseases as defined neurodegenerative diseases because they are caused by a degeneration of nerve cells. Recent studies conducted by international researchers have discovered that the cannabidiol, a component not psicoattivo of cannabis, helps protect the brain cells. The research, published in the scientific journal "Proceedings of National Academy", has demonstrated that the cannabidiol acts as an antioxidant, i.e. combats aging and death of neurons. Even if the studies are always at the experimental stage this discovery opens up new possibilities in the treatment of stroke and neurodegenerative disorders. The legislation in Italy and in the world adjusts the cannabis Italy - the legislation to consult is the Dpr number 309 of 9 October 1990: in our country are not for sale allopathic treatments which use cannabis indica, which instead is present in some homeopathic medicines, even if in small doses (are measured in nanograms, i.e. in billionths of a gram). Abroad, and exactly in the USA, Israel, Germany, Great Britain and the Netherlands there are two synthetic cannabinoids already in trade: dronabinol and nabilone. These drugs are sold on prescription to cure the side effects of chemotherapy and to stimulate the appetite in Aids patients, although by 2002 it will become possible to use them to combat the spasms of multiple sclerosis and other disorders. The Institute of Medicine of the National Academy of Sciences of the United States, last year has officially recognized the benefits derived from cannabis in the treatment of certain diseases. In the same document, however, the American organization has brought to the attention of the scientific world the problem of finding an administration of cannabis is different from tobacco smoke. In fact, the inhalation of cannabinoids through the smoke causes damage similar to those of the cigarettes that range from a simple irritation of the respiratory tract to problems much more serious, as the lung cancer. For this reason the international scientific community is trying administration methods alternative to smoke that, in sick people, has effects even more harmful. For now it is arrived to produce as an alternative to smoking pills, but their cost is very high, also the absorption through the gastrointestinal tract is very slow and a large part of the active principle is inactivated by the passage in the liver. Another way of administration that you are experiencing is that inhalant, i.e. the active principles of cannabis are inhaled as occurs during an aerosol and plasters that release through the skin these active substances.